{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:17:48Z","timestamp":1791425868249,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with multi-vessel coronary artery disease (MV-CAD) have poorer clinical outcomes than those with single-vessel coronary artery disease (SV-CAD). Solid evidence underlines that high-density lipoprotein cholesterol (HDL-C) plays a protective role and monocyte plays a negative role in coronary artery disease (CAD). However, the monocyte to high-density lipoprotein ratio (MHR) has not been studied in relation to MV-CAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, 640 patients underwent coronary angiography, of whom 225 had severe coronary artery disease. Then divide the above two groups of patients into three groups based on the MHR tertiles, respectively. Logistic regression and subgroup analysis were carried out to estimate the association between MHR and MV-CAD. The receiver operating characteristic (ROC) curve analysis was constructed by combining classic CAD risk factors with MHR in response to MV-CAD. In addition, the mediating effect of MHR between smoking and MV-CAD in suspected CAD Patients was analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the three MHR groups, a statistically discrepant was observed in the number of patients with CAD, Severe-CAD and MV-CAD (<jats:italic>P<\/jats:italic><jats:sub>CAD<\/jats:sub>\u2009&lt;\u20090.001; <jats:italic>P<\/jats:italic><jats:sub>Severe-CAD<\/jats:sub>\u2009&lt;\u20090.001; <jats:italic>P<\/jats:italic><jats:sub>MV-CAD<\/jats:sub>\u2009=\u20090.001) in suspected CAD patients. Furthermore, the number of patients with MV-CAD (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) was different in Severe-CAD patients among three MHR groups. Non-CAD and CAD patients showed statistically discrepant in MHR levels (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and this difference also was observed between SV-CAD and MV-CAD patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In the analysis of suspected CAD patients, a significantly positive relationship was found between MHR and CAD, Severe-CAD, and MV-CAD (<jats:italic>P<\/jats:italic> for trend\u2009&lt;\u20090.001). The effect of MHR on MV-CAD was consistent across all subgroups, with no significant randomized factor-by-subgroup interaction (<jats:italic>P<\/jats:italic>-interaction\u2009=\u20090.17\u20130.89). ROC analysis showed that the model constructed with MHR and classic influencing factors of CAD was superior to the model constructed solely based on classic influencing factors of CAD (0.742 vs.0.682, <jats:italic>P<\/jats:italic>\u2009=\u20090.002). In the analysis of Severe-CAD patients, patients with higher MHR levels had a higher risk of MV-CAD [OR (95%CI): 2.90 (1.49, 5.62), <jats:italic>P<\/jats:italic> for trend\u2009=\u20090.002] compared to patients with lower MHR. The trends persisted after adjusting for demographic (<jats:italic>P<\/jats:italic> for trend\u2009=\u20090.004) and classic influencing factors of CAD (<jats:italic>P<\/jats:italic> for trend\u2009=\u20090.009). All subgroup factors for patients with MV-CAD had no interaction with MHR (<jats:italic>P<\/jats:italic>-interaction\u2009=\u20090.15\u20130.86). ROC analysis showed that the model combining MHR and classic influencing factors of CAD was superior to the one including only the classic influencing factors of CAD (0.716 vs.0.650, <jats:italic>P<\/jats:italic>\u2009=\u20090.046). Assuming that MHR played a mediating effect between smoking and MV-CAD in suspected CAD patients. The results indicated that MHR played a partial mediating effect of 0.48 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A higher MHR was mainly associated with multi-vessel coronary artery disease and MHR partially mediated the association between smoking and MV-CAD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01897-x","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T11:02:34Z","timestamp":1691492554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association between monocyte to high-density lipoprotein cholesterol ratio and multi-vessel coronary artery disease: a cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiaqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"issue":"24","key":"1897_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1136\/heartjnl-2016-309573","volume":"102","author":"P Bhatnagar","year":"2016","unstructured":"Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK[J]. Heart. 2016;102(24):1945\u201352.","journal-title":"Heart"},{"issue":"4","key":"1897_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jamacardio.2021.5613","volume":"7","author":"YH Lee","year":"2022","unstructured":"Lee YH, Fang J, Schieb L, Park S, Casper M, Gillespie C. Prevalence and trends of coronary heart disease in the United States, 2011 to 2018[J]. JAMA Cardiol. 2022;7(4):459\u201362.","journal-title":"JAMA Cardiol"},{"issue":"4","key":"1897_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jacc.2003.08.050","volume":"43","author":"A Norhammar","year":"2004","unstructured":"Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Ryd\u00e9n L, Wallentin L. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization[J]. J Am Coll Cardiol. 2004;43(4):585\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"1897_CR4","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/eurheartj\/ehm184","volume":"28","author":"P Sorajja","year":"2007","unstructured":"Sorajja P, Gersh BJ, Cox DA, Mclaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction[J]. Eur Heart J. 2007;28(14):1709\u201316.","journal-title":"Eur Heart J"},{"issue":"6","key":"1897_CR5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.amjcard.2008.11.033","volume":"103","author":"F Cardarelli","year":"2009","unstructured":"Cardarelli F, Bellasi A, Ou FS, Shaw LJ, Veledar E, Roe MT, Morris DC, Peterson ED, Klein LW, Raggi P. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry)[J]. Am J Cardiol. 2009;103(6):766\u201371.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1897_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/2048872615626354","volume":"6","author":"L Feldman","year":"2017","unstructured":"Feldman L, Steg PG, Amsallem M, Puymirat E, Sorbets E, Elbaz M, Ritz B, Hueber A, Cattan S, Piot C, Ferri\u00e8res J, Simon T, Danchin N. Editor\u2019s Choice-Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease[J]. Eur Heart J Acute Cardiovasc Care. 2017;6(3):262\u201371.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"2","key":"1897_CR7","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, Dimaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint\u00a0Committee\u00a0on\u00a0Clinical Practice Guidelines[J]. J Am Coll Cardiol. 2022;79(2):e21\u2013129.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"1897_CR8","first-page":"1569","volume":"382","author":"SN Burgess","year":"2020","unstructured":"Burgess SN, Juergens CP, French JK. Complete Revascularization with Multivessel PCI for Myocardial Infarction[J]. N Engl J Med. 2020;382(16):1569\u201370.","journal-title":"N Engl J Med"},{"issue":"3","key":"1897_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2217\/fca-2020-0244","volume":"18","author":"A Nenna","year":"2022","unstructured":"Nenna A, Nappi F, Spadaccio C, Greco SM, Pilato M, Stilo F, Montelione N, Catanese V, Lusini M, Spinelli F, Chello M. Hybrid coronary revascularization in multivessel coronary artery disease: a systematic review[J]. Future Cardiol. 2022;18(3):219\u201334.","journal-title":"Future Cardiol"},{"issue":"11","key":"1897_CR10","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","volume":"28","author":"P Aukrust","year":"2008","unstructured":"Aukrust P, Halvorsen B, Yndestad A, Ueland T, \u00d8ie E, Otterdal K, Gullestad L, Dam\u00e5s JK. Chemokines and cardiovascular risk[J]. Arterioscler Thromb Vasc Biol. 2008;28(11):1909\u201319.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"1897_CR11","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice[J]. J Am Coll Cardiol. 2009;54(23):2129\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1897_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00281-009-0146-7","volume":"31","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Mach F. Atherosclerosis is an inflammatory disease[J]. Semin Immunopathol. 2009;31(1):1\u20133.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"1897_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1083\/jcb.201412052","volume":"209","author":"I Tabas","year":"2015","unstructured":"Tabas I, Garc\u00eda-Carde\u00f1a G, Owens GK. Recent insights into the cellular biology of atherosclerosis[J]. J Cell Biol. 2015;209(1):13\u201322.","journal-title":"J Cell Biol"},{"issue":"3","key":"1897_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","volume":"104","author":"P Libby","year":"2001","unstructured":"Libby P. Current concepts of the pathogenesis of the acute coronary syndromes[J]. Circulation. 2001;104(3):365\u201372.","journal-title":"Circulation"},{"issue":"2","key":"1897_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.mehy.2007.05.030","volume":"70","author":"Y Liu","year":"2008","unstructured":"Liu Y, Yu H, Zhang Y, Zhao Y. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target[J]. Med Hypotheses. 2008;70(2):314\u20136.","journal-title":"Med Hypotheses"},{"issue":"5","key":"1897_CR16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1189\/jlb.0206125","volume":"80","author":"P Ancuta","year":"2006","unstructured":"Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells[J]. J Leukoc Biol. 2006;80(5):1156\u201364.","journal-title":"J Leukoc Biol"},{"key":"1897_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","volume":"1","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Robertson AK, S\u00f6derberg-Naucl\u00e9r C. Inflammation and atherosclerosis[J]. Annu Rev Pathol. 2006;1:297\u2013329.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1897_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, Van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques[J]. J Clin Invest. 2007;117(1):185\u201394.","journal-title":"J Clin Invest"},{"issue":"6\u20138","key":"1897_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.imbio.2006.05.025","volume":"211","author":"F Tacke","year":"2006","unstructured":"Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets[J]. Immunobiology. 2006;211(6\u20138):609\u201318.","journal-title":"Immunobiology"},{"key":"1897_CR20","doi-asserted-by":"crossref","unstructured":"Kim KW, Ivanov S, Williams JW. Monocyte recruitment, specification, and function in atherosclerosis[J]. Cells. 2020;10(1):15.","DOI":"10.3390\/cells10010015"},{"issue":"27","key":"1897_CR21","doi-asserted-by":"publisher","first-page":"10340","DOI":"10.1073\/pnas.0604260103","volume":"103","author":"FK Swirski","year":"2006","unstructured":"Swirski FK, Pittet MJ, Kircher MF, Aikawa E, Jaffer FA, Libby P, Weissleder R. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease[J]. Proc Natl Acad Sci U S A. 2006;103(27):10340\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1897_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/0003319717704748","volume":"69","author":"N Acikgoz","year":"2018","unstructured":"Acikgoz N, Kurto\u011flu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Beh\u00e7et disease[J]. Angiology. 2018;69(1):65\u201370.","journal-title":"Angiology"},{"issue":"6","key":"1897_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00059-015-4393-1","volume":"41","author":"H Kundi","year":"2016","unstructured":"Kundi H, Kiziltunc E, Cetin M, Cicekcioglu H, Cetin ZG, Cicek G, Ornek E. Association of monocyte\/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease[J]. Herz. 2016;41(6):523\u20139.","journal-title":"Herz"},{"issue":"10","key":"1897_CR24","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1161\/01.ATV.0000094961.74697.54","volume":"23","author":"L Calabresi","year":"2003","unstructured":"Calabresi L, Gomaraschi M, Franceschini G. Endothelial protection by high-density lipoproteins: from bench to bedside[J]. Arterioscler Thromb Vasc Biol. 2003;23(10):1724\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1897_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/CS20080106","volume":"116","author":"F Tabet","year":"2009","unstructured":"Tabet F, Rye KA. High-density lipoproteins, inflammation and oxidative stress[J]. Clin Sci (Lond). 2009;116(2):87\u201398.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"1897_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.07.018","volume":"177","author":"AF Ayyobi","year":"2004","unstructured":"Ayyobi AF, Mcgladdery SH, Chan S, John Mancini GB, Hill JS, Frohlich JJ. Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up[J]. Atherosclerosis. 2004;177(2):361\u20136.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1897_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/07853890.2016.1168935","volume":"48","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li S, Guo YL, Wu NQ, Zhu CG, Gao Y, Xu RX, Dong Q, Liu G, Sun J, Li JJ. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography[J]. Ann Med. 2016;48(5):305\u201312.","journal-title":"Ann Med"},{"issue":"1","key":"1897_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12944-022-01742-7","volume":"21","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li D, Zhu X, Li J, Yue C, Wu L, Zhuan Q, Dou X, Duan W. The monocyte to high-density lipoprotein cholesterol ratio is a risk factor for frequent premature ventricular complexes: a retrospective cohort study[J]. Lipids Health Dis. 2022;21(1):129.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"1897_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00380-011-0130-8","volume":"27","author":"S Tani","year":"2012","unstructured":"Tani S, Matsumoto M, Anazawa T, Kawamata H, Furuya S, Takahashi H, Iida K, Washio T, Kumabe N, Kobori M, Nagao K, Hirayama A. Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count[J]. Heart Vessels. 2012;27(2):143\u201350.","journal-title":"Heart Vessels"},{"issue":"10","key":"1897_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2217\/bmm-2016-0157","volume":"10","author":"K Cagli","year":"2016","unstructured":"Cagli K, Tok D, Turak O, Gunertem E, Yayla C, Lafci G, Ulas MM, Cagli K. Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size[J]. Biomark Med. 2016;10(10):1039\u201347.","journal-title":"Biomark Med"},{"issue":"5","key":"1897_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.numecd.2016.12.005","volume":"27","author":"M Ruscica","year":"2017","unstructured":"Ruscica M, Baragetti A, Catapano AL, Norata GD. Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions[J]. Nutr Metab Cardiovasc Dis. 2017;27(5):379\u201395.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"1897_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2217\/bmm-2015-0050","volume":"10","author":"MK Akboga","year":"2016","unstructured":"Akboga MK, Balci KG, Maden O, Ertem AG, Kirbas O, Yayla C, Acar B, Aras D, Kisacik H, Aydogdu S. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease[J]. Biomark Med. 2016;10(4):375\u201383.","journal-title":"Biomark Med"},{"issue":"8","key":"1897_CR33","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.ajem.2016.05.031","volume":"34","author":"S Balta","year":"2016","unstructured":"Balta S, Celik T, Ozturk C, Kaya MG, Aparci M, Yildirim AO, Demir M, Kilic S, Aydin \u0130, Iyisoy A. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction[J]. Am J Emerg Med. 2016;34(8):1542\u20137.","journal-title":"Am J Emerg Med"},{"issue":"10","key":"1897_CR34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2217\/bmm.15.74","volume":"9","author":"EH Cetin","year":"2015","unstructured":"Cetin EH, Cetin MS, Canpolat U, Aydin S, Topaloglu S, Aras D, Aydogdu S. Monocyte\/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. Biomark Med. 2015;9(10):967\u201377.","journal-title":"Biomark Med"},{"issue":"11","key":"1897_CR35","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.hlc.2016.02.023","volume":"25","author":"MS Cetin","year":"2016","unstructured":"Cetin MS, Ozcan Cetin EH, Kalender E, Aydin S, Topaloglu S, Kisacik HL, Temizhan A. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome[J]. Heart Lung Circ. 2016;25(11):1077\u201386.","journal-title":"Heart Lung Circ"},{"issue":"2","key":"1897_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ajem.2015.10.049","volume":"34","author":"MB Karata\u015f","year":"2016","unstructured":"Karata\u015f MB, \u00c7anga Y, \u00d6zcan KS, \u0130pek G, G\u00fcng\u00f6r B, Onuk T, Durmu\u015f G, \u00d6z A, Karaca M, Bolca O. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention[J]. Am J Emerg Med. 2016;34(2):240\u20134.","journal-title":"Am J Emerg Med"},{"key":"1897_CR37","doi-asserted-by":"publisher","first-page":"869816","DOI":"10.3389\/fcvm.2022.869816","volume":"9","author":"Y Weng","year":"2022","unstructured":"Weng Y, Peng Y, Xu Y, Wang L, Wu B, Xiang H, Ji K, Guan X. The ratio of red blood cell distribution width to albumin is correlated with all-cause mortality of patients after percutaneous coronary intervention - a retrospective cohort study[J]. Front Cardiovasc Med. 2022;9:869816.","journal-title":"Front Cardiovasc Med"},{"issue":"19","key":"1897_CR38","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2014.15095","volume":"312","author":"DW Park","year":"2014","unstructured":"Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, Ohman EM, Van De Werf F, Hirji S, Harrington RA, Armstrong PW, Granger CB, Jeong MH, Patel MR. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction[J]. JAMA. 2014;312(19):2019\u201327.","journal-title":"JAMA"},{"issue":"29","key":"1897_CR39","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corr\u00e0 U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, L\u00f8chen ML, L\u00f6llgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Van Der Worp HB, Van Dis I, Verschuren WMM, Binno S. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)[J]. Eur Heart J. 2016;37(29):2315\u201381.","journal-title":"Eur Heart J"},{"issue":"6","key":"1897_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1037\/cou0000242","volume":"64","author":"MJ Valente","year":"2017","unstructured":"Valente MJ, Pelham WE, Smyth H, Mackinnon DP. Confounding in statistical mediation analysis: What it is and how to address it[J]. J Couns Psychol. 2017;64(6):659\u201371.","journal-title":"J Couns Psychol"},{"issue":"5","key":"1897_CR41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.imbio.2012.01.008","volume":"217","author":"A Gratchev","year":"2012","unstructured":"Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases[J]. Immunobiology. 2012;217(5):476\u201382.","journal-title":"Immunobiology"},{"issue":"7","key":"1897_CR42","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1253\/circj.CJ-09-0779","volume":"74","author":"N Nozawa","year":"2010","unstructured":"Nozawa N, Hibi K, Endo M, Sugano T, Ebina T, Kosuge M, Tsukahara K, Okuda J, Umemura S, Kimura K. Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction[J]. Circ J. 2010;74(7):1384\u201391.","journal-title":"Circ J"},{"issue":"Pt B","key":"1897_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.yjmcc.2015.10.029","volume":"89","author":"N Glezeva","year":"2015","unstructured":"Glezeva N, Horgan S, Baugh JA. Monocyte and macrophage subsets along the continuum to heart failure: Misguided heroes or targetable villains?[J]. J Mol Cell Cardiol. 2015;89(Pt B):136\u201345.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"1897_CR44","doi-asserted-by":"publisher","first-page":"300060521105989","DOI":"10.1177\/03000605211059893","volume":"49","author":"N Salehi","year":"2021","unstructured":"Salehi N, Janjani P, Tadbiri H, Rozbahani M, Jalilian M. Effect of cigarette smoking on coronary arteries and pattern and severity of coronary artery disease: a review[J]. J Int Med Res. 2021;49(12):3000605211059893.","journal-title":"J Int Med Res"},{"issue":"11","key":"1897_CR45","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/jcb.24581","volume":"114","author":"BM He","year":"2013","unstructured":"He BM, Zhao SP, Peng ZY. Effects of cigarette smoking on HDL quantity and function: implications for atherosclerosis[J]. J Cell Biochem. 2013;114(11):2431\u20136.","journal-title":"J Cell Biochem"},{"issue":"3","key":"1897_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0034-5687(98)00098-X","volume":"114","author":"S Bergmann","year":"1998","unstructured":"Bergmann S, Siekmeier R, Mix C, Jaross W. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1[J]. Respir Physiol. 1998;114(3):269\u201375.","journal-title":"Respir Physiol"},{"issue":"5","key":"1897_CR47","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/ATVBAHA.118.312338","volume":"39","author":"KM Pedersen","year":"2019","unstructured":"Pedersen KM, \u00c7olak Y, Ellervik C, Hasselbalch HC, Bojesen SE, Nordestgaard BG. Smoking and Increased White and Red Blood Cells[J]. Arterioscler Thromb Vasc Biol. 2019;39(5):965\u201377.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"1897_CR48","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/1076029615594002","volume":"22","author":"U Canpolat","year":"2016","unstructured":"Canpolat U, \u00c7etin EH, Cetin S, Aydin S, Akboga MK, Yayla C, Turak O, Aras D, Aydogdu S. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation[J]. Clin Appl Thromb Hemost. 2016;22(5):476\u201382.","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01897-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T14:19:34Z","timestamp":1700403574000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01897-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1897"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01897-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Research and Ethics Institute of the Second Affiliated Hospital of Wenzhou Medical University approved this study involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}